3034:HK:HK-CSOP Metaverse Concept ETF (HKD)

ETF | Others |

Last Closing

USD 9.46

Change

+0.05 (+0.53)%

Market Cap

N/A

Volume

0.11M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

-0.07 (-0.35%)

USD 140.29B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

-0.08 (-0.11%)

USD 21.11B
2823:HK iShares FTSE A50 China

+0.11 (+0.84%)

USD 18.01B
2801:HK iShares Core MSCI China ETF

-0.16 (-0.79%)

USD 17.11B
83188:HK ChinaAMC CSI 300 Index ETF

+0.18 (+0.46%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

-0.02 (-1.30%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

-0.12 (-1.20%)

USD 9.22B
82822:HK CSOP FTSE China A50

+0.11 (+0.96%)

USD 9.11B
9010:HK iShares Core MSCI AC Asia ex J..

+0.03 (+0.36%)

USD 3.03B

ETFs Containing 3034:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.99% 82% B 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.99% 82% B 78% C+
Trailing 12 Months  
Capital Gain 21.28% 73% C 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.28% 71% C- 72% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.94% 80% B- 69% C-
Dividend Return 7.94% 79% B- 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.79% 69% C- 88% B+
Risk Adjusted Return 57.59% 87% B+ 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike